Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 4.95
NAS:CSII's Cash-to-Debt is ranked higher than
56% of the 335 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. NAS:CSII: 4.95 )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:CSII' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.11  Med: N/A Max: No Debt
Current: 4.95
Equity-to-Asset 0.61
NAS:CSII's Equity-to-Asset is ranked lower than
54% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. NAS:CSII: 0.61 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:CSII' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.4  Med: 0.52 Max: 0.94
Current: 0.61
-1.4
0.94
Interest Coverage N/A
NAS:CSII's Interest Coverage is ranked higher than
73% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: 73.23 vs. NAS:CSII: N/A )
Ranked among companies with meaningful Interest Coverage only.
NAS:CSII' s Interest Coverage Range Over the Past 10 Years
Min: N/A  Med: No Debt Max: No Debt
Current: N/A
N/A
No Debt
Piotroski F-Score: 7
Altman Z-Score: 7.42
Beneish M-Score: -3.02
WACC vs ROIC
17.03%
-20.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % -3.75
NAS:CSII's Operating Margin % is ranked lower than
59% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. NAS:CSII: -3.75 )
Ranked among companies with meaningful Operating Margin % only.
NAS:CSII' s Operating Margin % Range Over the Past 10 Years
Min: -60.63  Med: -21.58 Max: 3.82
Current: -3.75
-60.63
3.82
Net Margin % -3.72
NAS:CSII's Net Margin % is ranked lower than
58% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. NAS:CSII: -3.72 )
Ranked among companies with meaningful Net Margin % only.
NAS:CSII' s Net Margin % Range Over the Past 10 Years
Min: -56.49  Med: -23.14 Max: 13.13
Current: -3.72
-56.49
13.13
ROE % -7.01
NAS:CSII's ROE % is ranked lower than
61% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. NAS:CSII: -7.01 )
Ranked among companies with meaningful ROE % only.
NAS:CSII' s ROE % Range Over the Past 10 Years
Min: -99.5  Med: -47.59 Max: 10
Current: -7.01
-99.5
10
ROA % -4.83
NAS:CSII's ROA % is ranked lower than
56% of the 336 Companies
in the Global Medical Devices industry.

( Industry Median: 0.33 vs. NAS:CSII: -4.83 )
Ranked among companies with meaningful ROA % only.
NAS:CSII' s ROA % Range Over the Past 10 Years
Min: -58.12  Med: -30.3 Max: 6.68
Current: -4.83
-58.12
6.68
ROC (Joel Greenblatt) % -18.00
NAS:CSII's ROC (Joel Greenblatt) % is ranked lower than
58% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: 5.51 vs. NAS:CSII: -18.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:CSII' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -4509.29  Med: -177.88 Max: 88.2
Current: -18
-4509.29
88.2
3-Year Revenue Growth Rate 4.60
NAS:CSII's 3-Year Revenue Growth Rate is ranked lower than
52% of the 243 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. NAS:CSII: 4.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NAS:CSII' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -7 Max: 23.9
Current: 4.6
0
23.9
3-Year EBITDA Growth Rate 16.90
NAS:CSII's 3-Year EBITDA Growth Rate is ranked higher than
63% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 5.60 vs. NAS:CSII: 16.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NAS:CSII' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -27.5 Max: 79.4
Current: 16.9
0
79.4
3-Year EPS without NRI Growth Rate 15.70
NAS:CSII's 3-Year EPS without NRI Growth Rate is ranked higher than
66% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. NAS:CSII: 15.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NAS:CSII' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -66.2  Med: -9.05 Max: 81.2
Current: 15.7
-66.2
81.2
GuruFocus has detected 3 Warning Signs with Cardiovascular Systems Inc $NAS:CSII.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:CSII's 30-Y Financials

Financials (Next Earnings Date: 2017-10-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:NAS:KTWO, NAS:VASC, OTCPK:NMRD, NAS:OFIX, OTCPK:MZRTF, NAS:BABY, OTCPK:SBMAF, NAS:XENT, NYSE:ITGR, NYSE:CRY, NAS:SPNC, NAS:GNMK, NAS:CNMD, NAS:AXGN, NAS:TCMD, NAS:EXAC, NAS:CYNO, NYSE:IVC, NAS:ELOS, NAS:ARAY » details
Traded in other countries:R7Y1.Germany,
Headquarter Location:USA
Cardiovascular Systems Inc is a medical technology company. It is engaged in developing, manufacturing, and marketing devices for the treatment of vascular diseases.

Cardiovascular Systems is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generates the vast majority of its revenue in the United States.

Ratios

vs
industry
vs
history
Forward PE Ratio 256.41
CSII's Forward PE Ratio is ranked lower than
98% of the 51 Companies
in the Global Medical Devices industry.

( Industry Median: 25.64 vs. CSII: 256.41 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 8.85
CSII's PB Ratio is ranked lower than
88% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 3.01 vs. CSII: 8.85 )
Ranked among companies with meaningful PB Ratio only.
CSII' s PB Ratio Range Over the Past 10 Years
Min: 0.18  Med: 5.72 Max: 14.5
Current: 8.85
0.18
14.5
PS Ratio 5.03
CSII's PS Ratio is ranked lower than
67% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.36 vs. CSII: 5.03 )
Ranked among companies with meaningful PS Ratio only.
CSII' s PS Ratio Range Over the Past 10 Years
Min: 0.24  Med: 2.45 Max: 7.6
Current: 5.03
0.24
7.6
Price-to-Free-Cash-Flow 92.65
CSII's Price-to-Free-Cash-Flow is ranked lower than
87% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 32.05 vs. CSII: 92.65 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CSII' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 81.2  Med: 94.25 Max: 172.72
Current: 92.65
81.2
172.72
Price-to-Operating-Cash-Flow 77.09
CSII's Price-to-Operating-Cash-Flow is ranked lower than
93% of the 136 Companies
in the Global Medical Devices industry.

( Industry Median: 20.50 vs. CSII: 77.09 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CSII' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 67.57  Med: 78.42 Max: 123.16
Current: 77.09
67.57
123.16
Current Ratio 3.93
CSII's Current Ratio is ranked higher than
70% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. CSII: 3.93 )
Ranked among companies with meaningful Current Ratio only.
CSII' s Current Ratio Range Over the Past 10 Years
Min: 1.27  Med: 3.93 Max: 17.17
Current: 3.93
1.27
17.17
Quick Ratio 3.50
CSII's Quick Ratio is ranked higher than
73% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. CSII: 3.50 )
Ranked among companies with meaningful Quick Ratio only.
CSII' s Quick Ratio Range Over the Past 10 Years
Min: 1.18  Med: 3.38 Max: 17.17
Current: 3.5
1.18
17.17
Days Inventory 157.21
CSII's Days Inventory is ranked lower than
59% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 131.96 vs. CSII: 157.21 )
Ranked among companies with meaningful Days Inventory only.
CSII' s Days Inventory Range Over the Past 10 Years
Min: 37.97  Med: 113.08 Max: 161.81
Current: 157.21
37.97
161.81
Days Sales Outstanding 50.76
CSII's Days Sales Outstanding is ranked higher than
77% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 68.17 vs. CSII: 50.76 )
Ranked among companies with meaningful Days Sales Outstanding only.
CSII' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.38  Med: 55.96 Max: 61.98
Current: 50.76
47.38
61.98
Days Payable 81.19
CSII's Days Payable is ranked higher than
66% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 55.39 vs. CSII: 81.19 )
Ranked among companies with meaningful Days Payable only.
CSII' s Days Payable Range Over the Past 10 Years
Min: 81.19  Med: 106.82 Max: 116.18
Current: 81.19
81.19
116.18

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -10.40
CSII's 3-Year Average Share Buyback Ratio is ranked lower than
68% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: -4.10 vs. CSII: -10.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CSII' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -242.8  Med: -47.9 Max: -10.4
Current: -10.4
-242.8
-10.4

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 33.08
CSII's Price-to-Net-Cash is ranked lower than
70% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 15.77 vs. CSII: 33.08 )
Ranked among companies with meaningful Price-to-Net-Cash only.
CSII' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.54  Med: 12.62 Max: 231.2
Current: 33.08
0.54
231.2
Price-to-Net-Current-Asset-Value 12.82
CSII's Price-to-Net-Current-Asset-Value is ranked lower than
70% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 6.67 vs. CSII: 12.82 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
CSII' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.53  Med: 7.18 Max: 27.54
Current: 12.82
0.53
27.54
Price-to-Tangible-Book 9.24
CSII's Price-to-Tangible-Book is ranked lower than
78% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 3.91 vs. CSII: 9.24 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CSII' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.52  Med: 6.25 Max: 12.81
Current: 9.24
0.52
12.81
Price-to-Median-PS-Value 2.05
CSII's Price-to-Median-PS-Value is ranked lower than
87% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 1.04 vs. CSII: 2.05 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CSII' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.28  Med: 1.08 Max: 2.91
Current: 2.05
0.28
2.91
Earnings Yield (Greenblatt) % -0.81
CSII's Earnings Yield (Greenblatt) % is ranked lower than
55% of the 334 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. CSII: -0.81 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CSII' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -6861.4  Med: -6.4 Max: 5408.1
Current: -0.81
-6861.4
5408.1

More Statistics

Revenue (TTM) (Mil) $200.45
EPS (TTM) $ -0.23
Beta2.48
Short Percentage of Float3.17%
52-Week Range $16.57 - 32.68
Shares Outstanding (Mil)32.71

Analyst Estimate

Jun17 Jun18
Revenue (Mil $)
EPS ($) -0.12 0.12
EPS without NRI ($) -0.12 0.12
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for CSII

Headlines

Articles On GuruFocus.com
Vaccine Small-Cap Just Took a Big Step Forward Jun 26 2017 
Annaly Capital Management: Attractive 9.5% Dividend Yield, but Interest Rates Are a Major Risk Jun 25 2017 
Never a Better Time to Pile on Chipotle Jun 25 2017 
Oracle Slowly Gaining Momentum on the Cloud Front Jun 26 2017 
Boeing Takes Lead Over Airbus With $30 Billion Worth of Orders on Day 1 of Paris Air Show Jun 25 2017 
Berkshire Hathaway’s Recent Investment: Home Capital Group Jun 25 2017 
Stocks That Fell to 3-Year Lows in the Week of June 23 Jun 24 2017 
Weekly Top Insider Buys Highlight for the Week of June 23 Jun 24 2017 
ID Watchdog Announces Special and Annual General Meeting Date and Record Date Jun 23 2017 
Ironclad Performance Wear Postpones 2017 Annual Meeting of Stockholders Jun 23 2017 

More From Other Websites
ETFs with exposure to Cardiovascular Systems, Inc. : June 26, 2017 Jun 26 2017
Cardiovascular Systems to Present at the JMP Securities Life Sciences Conference Jun 14 2017
Cardiovascular Systems, Inc. :CSII-US: Earnings Analysis: Q3, 2017 By the Numbers : June 14, 2017 Jun 14 2017
Cardiovascular Systems (CSII) Hits 52-Week High on Solid Q3 Jun 12 2017
Cardiovascular Systems Innovation On Track, Competition Rife Jun 07 2017
Cardiovascular Systems (CSII) Up 2.3% Since Earnings Report: Can It Continue? Jun 06 2017
Edited Transcript of CSII earnings conference call or presentation 3-May-17 8:45pm GMT May 07 2017
FDA Approves Cardiovascular Systems’ Replacement Saline Infusion Pump May 04 2017
Cardiovascular Systems (CSII) Swings to Earnings in Q3 May 04 2017
Cardiovascular Systems reports 3Q loss May 03 2017
Cardiovascular Systems, Inc. Reports Fiscal 2017 Third-Quarter Financial Results May 03 2017
Investor Network: Cardiovascular Systems, Inc. to Host Earnings Call May 03 2017
Zacks.com featured highlights: Cabot Oil & Gas, Cardiovascular Systems, Fortress Transportation and... Apr 26 2017
Thousands in Dallas May Be Affected by Peripheral Artery Disease (PAD) Apr 18 2017
Thousands in Philadelphia May Be Affected by Peripheral Artery Disease (PAD) Apr 18 2017
Thousands in Phoenix May Be Affected by Peripheral Artery Disease (PAD) Apr 18 2017
Thousands in Nashville May Be Affected by Peripheral Artery Disease (PAD) Apr 18 2017
Cardiovascular Systems Voluntarily Recalls 900 Pumps Apr 18 2017
Cardiovascular Systems Initiates Voluntary Recall of Saline Infusion Pump Apr 17 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}